News

Anti-ageing drug just a few years away. Researchers from the UNSW School of Medical Sciences and Harvard Medical School are just six months away from human trials of a new drug that appears to repair damaged DNA, reversing the effects of radiation and ageing.

Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800—1000 times the daily recommended amount of vitamin C as a potential strategy to improve outcomes of standard cancer treatments. In a work presented March 30, 2017 in Cancer Cell, University of Iowa researchers also show pathways by which altered iron metabolism in cancer cells, and not normal cells, lead to increased sensitivity to cancer cell death caused by high dose vitamin C.

A new study reveals the role of three proteins in killing fast-duplicating cancer cells while they're dividing. The research finds that these proteins can be specifically modified to unleash an inherent 'death mechanism' that self-eradicates duplicating cancer cells.

Researchers have identified a signaling molecule key to the formation of scar tissue surrounding implantable medical devices, a process called fibrosis. Blocking this molecule prevents scar tissue from forming and could help scientists extend the lifespan of many types of implantable medical devices.

Scientists have identified a drug candidate to restore heart muscle function following a heart attack. Currently, no drug exists to restore heart muscle function after a heart attack.

A small protein that could protect the brain from stroke-induced injury has been discovered by researchers from The University of Queensland and Monash University.